BIO supports all avenues of research to investigate therapies for debilitating diseases such as Parkinson's.
In this interview, BIO President and CEO Jim Greenwood explains the promise of stem cell research and why it is an important first step in bringing new therapies to patients.
Total job creation, accounting for economic multiplier effects, could reach 123,000 in 2012, 383,000 in 2016, and 807,000 by 2022.
Subscribe to Our Newsletter